Cancer screening in the elderly

European Journal of Surgical Oncology

Volumn 24, Issue 5, 1998, Pages 367-369

  Van Dongen, Joop A ^a  

^a NETHERLANDS CANCER INSTITUTE   (Netherlands)

Author keywords

Breast cancer; Cancer screening; Elderly; Prostate cancer

Indexed keywords

AGED; CANCER INCIDENCE; CANCER SCREENING; HUMAN; MASS SCREENING; PRIORITY JOURNAL; SHORT SURVEY; TUMOR;

EID: 0031725143     PISSN: 07487983     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0748-7983(98)91938-2     Document Type: Article

References (15)

1. Chamberlain J, Moss S. (eds). Evaluation of Cancer Screening. London: Springer Verlag, 1996.
2. van Wijngaarden WJ, Duncan, ID. Rationale for stopping cervical screening in women over 50. Br Med J 1993; 306: 967-71.
3. Fletcher SW, Black W, Harris R, Rimer BK, Shapiro S. Report of the International Workshop on Screening for Breast Cancer. J Natl Cancer Inst 1993; 85: 1645-56.
4. Visser O, Coebergh JWW, Schouten LJ, van Dijck JAAM. (eds). Incidence of Cancer in the Netherlands, 1994. Utrecht: Vereniging van Integrale Kankercentra, 1997.
5. Peer PGM, van Dijck JAAM, Hendriks, JHCL, Holland R, Verbeek ALM. Age-dependent growth rate of primary breast cancer. Cancer 1993; 71: 3547-51.
6. Nyström I. Rutquist LE, Wall S. et al. Breast cancer screening with mammography: overview of Swedish randomized trials. Lancet 1993; 341: 973-8.
7. van Dijck JAAM, Holland R, Verbeek ALM, Hendriks JHCL, Mravunac M. Efficacy of mammographic screening of the elderly: a case-refercnt study in the Nijmegen programme in the Netherlands. J Natl Cancer Inst 1994; 86: 934-8.
8. van Dijck JAAM, Verbeek ALM, Beex LVAM, et al. Mammographic screening after the age of 65 years: evidence for a reduction in breast cancer mortality. Int J Cancer 1996; 66: 727-31.
9. Habbema JDF, van Ootmarssen GJ, Lubbe JTN, van der Maas PJ. The MISCAN simulation program for the evaluation of screening for disease. Comput Methods Programs Biomed 1985; 20: 79-93.
10. de Koning HJ, van Ineveld BM, van Ootmarssen GJ, et al. Breast cancer screening and cost-effectiveness; policy alternatives, quality of life considerations and the possible impact of uncertain factors. Int J Cancer 1991; 49: 531-7.
11. Chamberlain J, Melia J. Screening for prostate cancer. In: Chamberlain J, Moss S (eds) Evaluation of Cancer Screening. London: Springer Verlag, 1996: 117-35.
12. Kramer BS, Brown ML, Prorok PC, Potosky AL, Gohagen JK. Prostate cancer screening: what we know and what we need to know. Ann Intern Med 1993; 119: 914-23.
13. Pedersen KV, Carlsson P. Varenhorst E, Lofman O, Berglund K. Screening for carcinoma of the prostate by digital rectal examination in a randomly selected population. Br Med J 1990; 300: 1041-4.
14. Miller AB. Issues in screening for prostate cancer. In: Miller AB, Chamberlain J, Day NE, Hakama M, Prorok P (eds) Cancer Screening. Cambridge: Cambridge University Press, 1991: 289-93.
15. Adami HO. Baron JA, Rothman KJ. Ethics of a prostate cancer screening trial. Lancet 1994; 343: 958-60.